These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 1981176)

  • 1. MIF-1 and Tyr-MIF-1 do not alter GABA binding on the GABAA receptor.
    Miller LG; Kastin AJ
    Brain Res Bull; 1990 Dec; 25(6):917-8. PubMed ID: 1981176
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MIF-1 and Tyr-MIF-1 augment GABA-stimulated benzodiazepine receptor binding.
    Miller LG; Kastin AJ
    Peptides; 1987; 8(5):751-5. PubMed ID: 2893356
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of Tyr-MIF-1 and MIF-1 at the GABAA receptor chloride channel site.
    Miller LG; Kastin AJ; Roy RB
    Brain Res Bull; 1987 Dec; 19(6):743-5. PubMed ID: 2449939
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structural specificity of MIF-1 and Tyr-MIF-1 in augmenting GABA-stimulated benzodiazepine receptor binding.
    Miller LG; Kastin AJ; Roy RB; Gaver A; Fischman AJ; Horvath A
    Res Commun Chem Pathol Pharmacol; 1988 Nov; 62(2):365-8. PubMed ID: 2908009
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MIF-1 and Tyr-MIF-1 augment muscimol-stimulated chloride uptake in cerebral cortex.
    Miller LG; Kastin AJ; Roy RB
    Brain Res Bull; 1989 Dec; 23(6):413-5. PubMed ID: 2575438
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tyr-MIF-1 binding in brain is not altered by ligands selective for the GABAA/benzodiazepine receptor.
    Zadina JE; Kastin AJ; Ge LJ
    Neurosci Lett; 1990 Mar; 110(1-2):143-7. PubMed ID: 1970141
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tyr-MIF-1 augments benzodiazepine receptor binding in vivo.
    Miller LG; Kastin AJ; Greenblatt DJ
    Pharmacol Biochem Behav; 1987 Dec; 28(4):521-4. PubMed ID: 2893390
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential effects of Tyr-MIF-1 and naloxone in two animal models involving benzodiazepine.
    Kastin AJ; Schwartzenburg D; Tsui L; Miller LG; Olson GA; Olson RD
    Brain Res Bull; 1989 Dec; 23(6):443-6. PubMed ID: 2575442
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel GABAA antagonist [3H]SR 95531: microscopic analysis of binding in the rat brain and allosteric modulation by several benzodiazepine and barbiturate receptor ligands.
    McCabe RT; Wamsley JK; Yezuita JP; Olsen RW
    Synapse; 1988; 2(2):163-73. PubMed ID: 2844001
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of the binding of [3H]SR 95531, a GABAA antagonist, to rat brain membranes.
    Heaulme M; Chambon JP; Leyris R; Wermuth CG; Biziere K
    J Neurochem; 1987 Jun; 48(6):1677-86. PubMed ID: 3033146
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of binding sites for N-Tyr-MIF-1 (Tyr-Pro-Leu-Gly-NH2) in rat brain.
    Zadina JE; Kastin AJ; Krieg EF; Coy DH
    Pharmacol Biochem Behav; 1982 Dec; 17(6):1193-8. PubMed ID: 6131435
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MIF-1 and Tyr-MIF-1 fail to alter benzodiazepine-induced hypothermia.
    Kastin AJ; Miller LG; Schwartzenburg DS
    Pharmacol Biochem Behav; 1989 May; 33(1):261-3. PubMed ID: 2571169
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An arylaminopyridazine derivative of gamma-aminobutyric acid (GABA) is a selective and competitive antagonist at the GABAA receptor site.
    Chambon JP; Feltz P; Heaulme M; Restle S; Schlichter R; Biziere K; Wermuth CG
    Proc Natl Acad Sci U S A; 1985 Mar; 82(6):1832-6. PubMed ID: 2984669
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Binding of Tyr-W-MIF-1 (Tyr-Pro-Trp-Gly-NH2) and related peptides to mu 1 and mu 2 opiate receptors.
    Zadina JE; Paul D; Gergen KA; Ge LJ; Hackler L; Kastin AJ
    Neurosci Lett; 1996 Aug; 215(1):65-9. PubMed ID: 8880755
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biochemical characterization of the interaction of three pyridazinyl-GABA derivatives with the GABAA receptor site.
    Heaulme M; Chambon JP; Leyris R; Molimard JC; Wermuth CG; Biziere K
    Brain Res; 1986 Oct; 384(2):224-31. PubMed ID: 3022866
    [TBL] [Abstract][Full Text] [Related]  

  • 16. From MIF-1 to endomorphin: the Tyr-MIF-1 family of peptides.
    Pan W; Kastin AJ
    Peptides; 2007 Dec; 28(12):2411-34. PubMed ID: 17988762
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mu, delta, and kappa opiate receptor binding of Tyr-MIF-1 and of Tyr-W-MIF-1, its active fragments, and two potent analogs.
    Zadina JE; Kastin AJ; Ge LJ; Hackler L
    Life Sci; 1994; 55(24):PL461-6. PubMed ID: 7990646
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tyr-MIF-1 attenuates development of tolerance to spiperone-induced catalepsy in rats.
    Kostrzewa RM; Kastin AJ
    Brain Res Bull; 1993; 31(6):707-12. PubMed ID: 8100182
    [TBL] [Abstract][Full Text] [Related]  

  • 19. GABAA receptor populations bind agonists and antagonists differentially and with opposite affinities.
    Maksay G
    J Neurochem; 1988 Jun; 50(6):1865-71. PubMed ID: 2836561
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structure-activity relationships of analogs of the endogenous brain peptides Tyr-MIF-1 and Tyr-W-MIF-1.
    Erchegyi J; Zadina JE; Qiu XD; Kersh DC; Ge LJ; Brown MM; Kastin AJ
    Pept Res; 1993; 6(1):31-8. PubMed ID: 8094991
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.